BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11877060)

  • 1. [Exploration of high expressions of retroviral vectors containing hFIX minigene in murine myoblast cells].
    Hou J; Wang J; Min B
    Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):121-4. PubMed ID: 11877060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid retroviral vector with MCK enhancers inserted in LTR for stable and specific expression of human factor IX in skeletal muscle.
    Wang JM; Hou J; Qiu XF; Kurachi K; Xue JL
    Chin Med J (Engl); 2004 Jun; 117(6):893-8. PubMed ID: 15198894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
    Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
    Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lasting expression of hF IX mediated by myoblasts in mice].
    Wang H; Yang X; Bao Y; Xue J
    Zhonghua Xue Ye Xue Za Zhi; 1997 Sep; 18(9):471-3. PubMed ID: 15625839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
    Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
    Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Splicing and stability of intron in the expression retroviral vector with human clotting factor IX].
    Xing YN; Lu DR; Gao XB; Qiu XF; Xue JL
    Yi Chuan Xue Bao; 1998 Dec; 25(6):471-7. PubMed ID: 10465892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice.
    Yao SN; Smith KJ; Kurachi K
    Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increment of hFIX expression with endogenous intron 1 in vitro.
    Zheng B; Qiu XY; Tan M; Xing YN; Lo D; Xue JL; Qiu XF
    Cell Res; 1997 Jun; 7(1):21-9. PubMed ID: 9261559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells.
    Wen J; Vargas AG; Ofosu FA; Hortelano G
    J Gene Med; 2006 Mar; 8(3):362-9. PubMed ID: 16311997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B].
    Peng JQ; Dong XY; Peng M; Chen L; Tan SP; Yuan H; Chen FP; Xue JL; Wu XB
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):513-8. PubMed ID: 15569526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors.
    Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA
    Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice.
    Wen J; Xu N; Li A; Bourgeois J; Ofosu FA; Hortelano G
    J Gene Med; 2007 Nov; 9(11):1002-10. PubMed ID: 17868187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic control elements promote long-term expression of human coagulation factor IX gene in hydrodynamically transfected mice.
    Kim HS; Kim JC; Lee YK; Kim JS; Park YS
    J Gene Med; 2011 Jul; 13(7-8):365-72. PubMed ID: 21710610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors.
    Dai YF; Qiu XF; Xue JL; Liu ZD
    Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice.
    Sclimenti CR; Neviaser AS; Baba EJ; Meuse L; Kay MA; Calos MP
    Biotechnol Prog; 2003; 19(1):144-51. PubMed ID: 12573017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and high expression of retroviral vector with human clotting factor IX cDNA in vitro.
    Lu D; Qiu X; Zheng B; Qiu X; Xue J
    Sci China B; 1995 Jun; 38(6):705-12. PubMed ID: 7626200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of human factor IX cDNA in mice by implants of genetically modified skin fibroblasts from a hemophilia B patient.
    Zhou JM; Dai YF; Qiu XF; Hou GY; Akira Y; Xue JL
    Sci China B; 1993 Sep; 36(9):1082-92. PubMed ID: 8274202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent expression of canine factor IX in hemophilia B canines.
    Chao H; Samulski R; Bellinger D; Monahan P; Nichols T; Walsh C
    Gene Ther; 1999 Oct; 6(10):1695-704. PubMed ID: 10516718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-viral gene transfer results in therapeutic factor IX levels in haemophilia B mice].
    Schüttrumpf J; Milanov P; Roth S; Seifried E; Tonn T
    Hamostaseologie; 2008 Oct; 28 Suppl 1():S92-5. PubMed ID: 18958345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient delivery of human clotting factor IX after injection of lentiviral vectors in utero.
    Chen XG; Zhu HZ; Gong JL; Li F; Xue JL
    Acta Pharmacol Sin; 2004 Jun; 25(6):789-93. PubMed ID: 15169633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.